Report offers ways to address cybersecurity challenges posed by legacy medical devices
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
New guidance from the Cybersecurity and Infrastructure Security Agency encourages healthcare organizations to consider internal network and internet facing…
Headline
The National Institute of Standards and Technology and the Cybersecurity and Infrastructure and Security Agency have released guidelines to protect…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
The National Security Agency has released a best practices guide on effective cyber hygiene for defending against advanced cyber threats, including those…
Headline
An FBI alert released Sept. 1 warns of cyber actors impersonating government officials, media and other public individuals on a commercial messaging app to…
Headline
In this conversation, John Riggi, AHA national advisor for cybersecurity and risk, and Scott Gee, AHA deputy national advisor for cybersecurity and risk, break…